Waters, Thermo Post Strong Q1 Revenue Growth; Cautiously Optimistic on Large Pharma Spending | GenomeWeb

Officials from Thermo Electron and Waters expressed cautious optimism about big pharma's future spending on big-ticket research instruments as both firms reported strong revenue growth for the first quarter of 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.